NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD (BETA)
  • XY Feed
  • 24-HOUR Pass →
Sign in Subscribe

Cardone Ventures Makes $89M Bid for PetMeds

Cardone Ventures, led by Grant Cardone and Brandon Dawson, submits $4.25/share cash offer to acquire PetMed Express, valuing the pet pharmacy at $89 million.

Cardone Ventures Makes $89M Bid for PetMeds
Photo by Krista Mangulsone on Unsplash
Already have an account? Sign in.
12/16/2025 · 12:57 PM
PETS
/ Don’t stop at just one post.

Related↓

PetMed Shares Surge on $4 Buyout Proposal from SilverCape Investments
12/11/2025 · 11:52 AM

PetMed Shares Surge on $4 Buyout Proposal from SilverCape Investments

PetMed stock jumps after revealing a $4-per-share take-private proposal from SilverCape Investments. The board is reviewing the unsolicited offer amid years of declining performance.

/ Subscriber only
/ Read more

Feed↓

SpaceX to Join Nasdaq-100 on July 7: $4.3 Billion Passive Buying Wave Incoming
Featured/ 06/27/2026 · 1:18 AM

SpaceX to Join Nasdaq-100 on July 7: $4.3 Billion Passive Buying Wave Incoming

Despite the massive demand boost, analysts remain cautious, citing the company’s $4.9 billion net loss last year and concerns over valuation.

/ Subscriber only
Lantheus Gets FDA CRL for LNTH-2501; No Safety or Efficacy Concerns Raised
06/26/2026 · 4:53 PM

Lantheus Gets FDA CRL for LNTH-2501; No Safety or Efficacy Concerns Raised

The delay is due to manufacturing issues at a third-party facility, with no safety or clinical data concerns.

/ Subscriber only
Ardelyx Suffers Legal Setback as Appeals Court Confirms XPHOZAH in Medicare Bundle
06/26/2026 · 3:43 PM

Ardelyx Suffers Legal Setback as Appeals Court Confirms XPHOZAH in Medicare Bundle

Ardelyx shares fell after losing a court case on Xphozah Medicare coverage, moving drug into bundled payments, hurting revenue outlook.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe